Profile Banner
SM

Samuel Murphy Email & Phone Number

Chief Executive Officer | Cambridge, Massachusetts, United States, North America

View Samuel Murphy Email & Phone Number

About Samuel Murphy

Samuel Murphy is a Chief Executive Officer at Salubris Biotherapeutics, Inc based in Cambridge, Massachusetts, United States, North America. Catalyzing global growth and technological innovation through innovative R&D focused on complex biologics and a broad business development mandate spanning licensing, acquisitions and strategic investments. Focus on cardiometabolic disease and oncology. Initiating first ever clinical trial of a bi-specific antibody in a cardiovascular indication (heart failure - https://clinicaltrials.gov/ct2/show/NCT04210375).

Current Position: Chief Executive Officer

Company: Salubris Biotherapeutics, Inc

Location: Cambridge, Massachusetts, United States, North America

Social: Professional profiles available

Network: Extensive professional connections

Read more

Samuel Murphy's Email Addresses

  • Sa****o@argotpartners.com
    Company

Samuel Murphy's Phone Numbers

  • (••) ••• ••• 951
    Company
View Email & Phone Number

Frequently Asked Questions
about Samuel Murphy

  • What is Samuel Murphy's phone number?

    Samuel Murphy's phone number is (••) ••• ••• 951.

  • How to contact Samuel Murphy?

    To contact Samuel Murphy, send an email to Sa****o@argotpartners.com. You can also reach out via their LinkedIn profile.

  • What is Samuel Murphy's current role?

    Samuel Murphy currently works as Chief Executive Officer at Salubris Biotherapeutics, Inc.They are located in Cambridge, Massachusetts, United States, North America.

  • How do I get in touch with Samuel Murphy?

    To reach Samuel Murphy, try sending your message to Sa****o@argotpartners.com. Additionally, you can connect with them on LinkedIn. For business inquiries, you can contact their company at Sa****o@argotpartners.com.

  • What does Samuel Murphy do at Salubris Biotherapeutics, Inc?

    Samuel Murphy serves as Chief Executive Officer at Salubris Biotherapeutics, Inc.Catalyzing global growth and technological innovation through innovative R&D focused on complex biologics and a broad business development mandate spanning licensing, acquisitions and strategic investments. Focus on cardiometabolic disease and oncology. Initiating first ever clinical trial of a bi-specific antibody in a cardiovascular indication (heart failure - https://clinicaltrials.gov/ct2/show/NCT04210375).